98%
921
2 minutes
20
Autoimmune hepatitis (AIH) is a distinct clinical entity with variable presentations and diverse clinical outcomes, characterized by autoimmune-mediated injury to the liver. The detection of autoantibodies and histological features consistent with autoimmune injury is crucial for diagnosing AIH. Early identification and treatment are essential to prevent progression to cirrhosis. This report describes five cases of AIH diagnosed and managed over one year, with presentations ranging from acute hepatitis to end-stage liver disease. Younger patients demonstrated good clinical and biochemical responses to immunosuppressive therapy, while an older patient with established cirrhosis faced a grim prognosis. AIH should be considered, particularly in female patients and in those without obvious risk factors for liver injury, such as alcohol use, drug-induced liver injury, or viral hepatitis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11699844 | PMC |
http://dx.doi.org/10.7759/cureus.75152 | DOI Listing |
Medicine (Baltimore)
September 2025
College of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Observational studies suggest associations between elevated body mass index (BMI) and autoimmune liver diseases (AILDs), yet causal evidence remains limited. This Mendelian randomization (MR) study aimed to elucidate the causal role of BMI in AILDs and identify mediating pathways involving 91 circulating cytokines. Utilizing public genome-wide association study data, univariate and multivariate MR analyses were conducted to assess causal relationships between BMI and 3 AILDs.
View Article and Find Full Text PDFClin Res Hepatol Gastroenterol
September 2025
Clalit Health Services, Northern Region, Israel; Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Background: Autoimmune hepatitis (AIH) is a chronic immune-mediated liver disease with a recognized, but incompletely defined, association with inflammatory bowel disease (IBD). The long-term risk of developing IBD in AIH patients and its influence on hepatic outcomes remain unclear.
Aim: To determine the incidence and risk factors for IBD in a large AIH cohort over a 20-year follow-up and to assess its impact on liver-related complications.
J Viral Hepat
October 2025
Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt.
Chronic liver disease (CLD) is a leading cause of global morbidity and mortality, necessitating effective preventive strategies. Growing evidence is linking coffee consumption with reduced risk of disease progression in various CLDs, including metabolic dysfunction associated steatotic liver disease (MASLD), alcoholic liver disease, hepatitis B and C, autoimmune hepatitis, and a reduction in the risk of hepatocellular carcinoma development. Coffee, a globally consumed beverage, contains bioactive compounds like caffeine, chlorogenic acids, diterpenes, and polyphenols, which may offer hepatoprotective benefits through anti-inflammatory, antioxidant, and metabolic regulatory effects.
View Article and Find Full Text PDFJ Hepatol
September 2025
Department of Pathology, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Greece; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, UK; European Reference Network on Hepatological Diseases (ERN RARE-LIVER).
Cureus
August 2025
Department of Rheumatology, Faculty of Medicine and Pharmacy, Ibn ROCHD University Hospital, Casablanca, MAR.
Peliosis hepatis is a rare condition characterized by dilation of the hepatic sinusoids and the presence of multiple blood-filled cystic spaces within the liver parenchyma. It has been associated with a variety of etiologies, including infectious diseases, immunological disorders, malignancy, and certain medications. We report a case of a 24-year-old male who presented with polyarthritis lasting two months.
View Article and Find Full Text PDF